<p>Fig. 2A showed the difference in the cumulative rate of relapse between age≤37 and age>37 (<i>P</i><0.05). Fig. 2B showed the difference in the cumulative rate of relapse between ALT>80 U/L and ALT≤80 U/L (<i>P</i><0.05). Fig. 2C showed the difference between the time period of the prolonged consolidation therapy>11 months and that ≤11 months (<i>P</i><0.05).</p
<p><i>n</i>, number of patients in subgroup of interest. aOR, adjusted odds ratios—adjustment descri...
BACKGROUND: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolo...
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...
<p>Group A, 40 patients without the prolonged consolidation therapy. Group B, 96 patients with the d...
The cumulative relapse-free rate was 76.2% and 46.4% at 24 and 96 months, respectively.</p
<p>Comparison of duration from starting the therapy to renal relapse in patients with DBP>80 mmHg an...
<p>Isolated (iCNS) and combined (c-CNS) relapses occur significantly earlier than those with isolate...
<p>(A) Therapeutic failure, which includes both induction failures and second relapses. (B) Treatmen...
<p>(A) Cumulative risk of locoregional relapse: 5.7% (95% CI, 0.7–10.7%) at 2 years and 11.3% (95% C...
Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolonged consoli...
Overall cure rate A) children ≤ 10 years of age, B) adults ≥ 60 years of age. Detailed description o...
<p>Comparison of duration from starting the therapy to renal relapse in male patients and female pat...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0053996#pone-0053996-g001" ...
Differences in relapse or recurrence and costs over 12 months between S-PCT and TAU; ICER, CE-planes...
<p>A. Annualized relapse, rate (ARR) during the first year of fingolimod treatment compared to the y...
<p><i>n</i>, number of patients in subgroup of interest. aOR, adjusted odds ratios—adjustment descri...
BACKGROUND: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolo...
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...
<p>Group A, 40 patients without the prolonged consolidation therapy. Group B, 96 patients with the d...
The cumulative relapse-free rate was 76.2% and 46.4% at 24 and 96 months, respectively.</p
<p>Comparison of duration from starting the therapy to renal relapse in patients with DBP>80 mmHg an...
<p>Isolated (iCNS) and combined (c-CNS) relapses occur significantly earlier than those with isolate...
<p>(A) Therapeutic failure, which includes both induction failures and second relapses. (B) Treatmen...
<p>(A) Cumulative risk of locoregional relapse: 5.7% (95% CI, 0.7–10.7%) at 2 years and 11.3% (95% C...
Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolonged consoli...
Overall cure rate A) children ≤ 10 years of age, B) adults ≥ 60 years of age. Detailed description o...
<p>Comparison of duration from starting the therapy to renal relapse in male patients and female pat...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0053996#pone-0053996-g001" ...
Differences in relapse or recurrence and costs over 12 months between S-PCT and TAU; ICER, CE-planes...
<p>A. Annualized relapse, rate (ARR) during the first year of fingolimod treatment compared to the y...
<p><i>n</i>, number of patients in subgroup of interest. aOR, adjusted odds ratios—adjustment descri...
BACKGROUND: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolo...
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...